Skadden counsels health care and life sciences clients in the areas of transactional, litigation and enforcement, regulatory, finance and intellectual property matters. We represent companies and investors around the globe in every sector of the industry, including pharmaceutical, biotechnology and medical device companies; hospital and health care systems; long-term care facilities; and other service providers. We work with clients on matters of all sizes, from the largest mergers in the industry to smaller, early-stage transactions.

Our attorneys provide our clients with a unique combination of leading transactional capabilities, as well as broad regulatory and litigation experience.

  • We offer a full-range of services, including advising on M&A, corporate restructurings, financings, private equity, complex licensing transactions, product liability defenses, intellectual property matters, regulatory counseling, global and U.S. investigations and enforcement, antitrust matters, securities litigation matters and related legal services.
  • Our global footprint with 22 offices in the Americas, Europe and Asia Pacific allows our attorneys to work seamlessly across our corporate, litigation and regulatory practices to provide service that balances the business prerogatives of our clients with the legal demands on the industry.
  • Our extensive work in health care provides our attorneys with current, sector-specific insights that make our legal advice timely and relevant in the fast-moving health care and life sciences industries.

Our clients include one-half of the top 40 global pharmaceutical companies and one-quarter of the top 40 global medical device companies (by market capitalization), as well as numerous emerging biotechnology and health care businesses. Some of the largest publicly traded and not-for-profit health care systems are represented by our attorneys. Skadden received two Finance and Transactional Deal of the Year awards from LMG Life Sciences in 2018 and has been included among the leading law firms by LMG Life Sciences in its 2016 rankings. We ranked first by value in global pharma and biotech M&A by mergermarket for 2015. Skadden also was named both Health Care and Life Sciences Groups of the Year by Law360 for 2014. Additionally, we were named The American Lawyer’s 2018 White Collar/Regulatory Litigation Department of the Year and the New York Law Journal’s 2018 Litigation Department of the Year.